| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 2007, p. 3671-3679, Vol. 45, No. 11
0095-1137/07/$08.00+0 doi:10.1128/JCM.01086-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

and
Hiroaki Okamoto1*
Division of Virology, Department of Infection and Immunity,1 Department of Nephrology, Jichi Medical University School of Medicine, Tochigi-Ken, Japan,2 Aikawa Internal Medicine Hospital, Ibaraki-Ken, Japan,3 Department of Internal Medicine, Metropolitan Toshima Hospital, Tokyo, Japan,4 Center for Gastroenterology, Kobayashi Hospital, Hokkaido, Japan,5 Department of Internal Medicine, Kin-ikyo Chuo Hospital, Hokkaido, Japan6
Received 29 May 2007/ Returned for modification 6 August 2007/ Accepted 20 August 2007
To investigate the duration of fecal shedding and changing loads of hepatitis E virus (HEV) in feces and serum from patients with acute HEV infection, HEV RNA was quantitated in periodic serum and fecal specimens obtained from 11 patients with sporadic acute hepatitis E. All 11 patients had detectable HEV RNA in serum at admission, with the highest viral load being 1.9 x 103 to 1.7 x 107 copies/ml, and HEV viremia lasted until days 17 to 48 (mean, 28.3) after the onset of hepatitis. Even at the initial examination on days 10 to 29 (mean, 17.6), the HEV load in fecal supernatant was less than 5.7 x 104 copies/ml for 10 of the 11 patients, while for the remaining patient (patient 1) it was markedly high, 2.0 x 107 copies/ml on day 22. In addition, although HEV RNA in fecal supernatant continued to be positive until days 14 to 33 (mean, 22.4) for patients 2 to 11, that for patient 1 was detectable even on day 121. HEVs in fecal specimens obtained on days 22, 24, 26, 28, and 30, but not day 121, from patient 1 grew efficiently in PLC/PRF/5 cells, reaching the highest titer of up to 107 copies/ml in culture medium on day 50 postinoculation. The HEV genome recovered from patient 1 had 29 unique nucleotides that were not seen in any of the 25 reported HEV isolates of the same genotype over the entire genome, with six amino acid substitutions in the ORF1 protein.
Published ahead of print on 29 August 2007.
Present address: Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|